Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Ophthalmology

Tracking Symptoms and Understanding Progression

At a Glance

Laurence-Moon syndrome can progress differently for each person, affecting vision, balance and movement, and hormone function. Track gradual changes with your care team, but seek emergency help for sudden vision loss, severe weakness, fainting, or breathing or swallowing problems.

Laurence-Moon syndrome (LMS) is a complex condition that unfolds differently for every person. Because it is part of a spectrum of disorders caused by changes in the PNPLA6 gene, your symptoms and how they change over time will not follow a single, predictable path [1][2]. While some patients notice vision changes in childhood and movement issues much later, others may experience these symptoms in a completely different order or at different ages.

This condition is generally characterized by varying degrees of involvement in your vision, your movement, and your hormones [3].

The Three Areas of Progression

1. Vision (Chorioretinal Dystrophy)

The eyes are frequently affected by PNPLA6 changes, leading to chorioretinal dystrophy, a progressive breakdown of the light-sensing layers at the back of the eye [4].

  • Early Signs: Many people first notice difficulty seeing at night or in low-light environments.
  • Visual Fields: Over time, peripheral (side) vision may narrow. While formal visual-field testing is required to map out your specific pattern of vision loss, some patients develop a blind spot called a scotoma, or may be left with only “islands” of sight [5].
  • Stability vs. Change: It is common for structural changes in the eye to progress faster than your actual vision loss. You may have periods where your vision feels stable even if your eye doctor sees changes on a scan [6].

2. Movement and Balance (Ataxia and Spasticity)

Neurological symptoms in LMS often develop slowly, though the rate varies widely [1].

  • Ataxia: This is a lack of coordination that can cause a “wide-based gait” (walking with your feet far apart for balance) or clumsiness with your hands [7].
  • Spasticity: Some patients experience spastic paraplegia, which is a stiffness or “tightness” in the leg muscles that can make movements feel jerky or difficult [1][8].
  • Speech: You may eventually notice dysarthria, a slurring or slowing of speech caused by changes in the part of the brain that coordinates the muscles used for talking [7].

3. Hormones (Hypogonadotropic Hypogonadism)

The PNPLA6 gene affects the pituitary gland, which acts as the body’s control center for many hormones. This can lead to hypogonadotropic hypogonadism, where the body does not produce enough of the hormones needed for sexual development [1]. This typically results in delayed puberty or an absence of secondary sexual characteristics (like a deepening voice or breast development) [9]. Some patients may also experience broader pituitary deficiencies, such as a lack of growth hormone.

Monitoring for “Red Flags” and Emergencies

While the typical progression of LMS is often gradual, certain symptoms require immediate medical evaluation. It is vital to distinguish between expected, slow changes and sudden medical emergencies.

Seek Emergency Care If You Experience:

  • Signs of Adrenal Crisis: Some individuals with specific PNPLA6 phenotypes may develop adrenal insufficiency (a lack of stress hormones like cortisol) [10]. Seek immediate emergency care for profound weakness, unexplained severe vomiting, severe dehydration, confusion, fainting, or dangerously low blood pressure. (Note: A single morning cortisol blood test does not reliably rule this out; it requires specialized evaluation by an endocrinologist.)
  • Sudden Vision Loss: While gradual vision decline is expected, any abrupt “blacking out” or sudden, rapid loss of vision is a medical emergency [11].
  • Sudden Neurological Changes: New, rapid difficulty swallowing (frequent choking), sudden breathing difficulties, or an abrupt loss of previously acquired physical abilities [12].

Contact Your Usual Care Team For:

  • Gradual Walking Changes: A slow decline in your ability to walk or a gradual increase in falls [7]. Even if changes are gradual, you should report them so your team can adjust your physical therapy or mobility aids.
  • Slow Vision Changes: Gradual worsening of night vision or side vision.

Remember, you do not have to monitor this alone. Keep a symptom log and share any new or worsening changes with your multidisciplinary care team.

Common questions in this guide

What vision changes can happen in Laurence-Moon syndrome?
Vision problems may start with difficulty seeing in dim light or at night. Over time, side vision may narrow, and some people develop blind spots; changes seen on an eye scan can progress before the person notices a major change in vision.
What movement or speech changes should I track with LMS?
Watch for poor coordination, a wide-based walk, hand clumsiness, increasing falls, or stiffness and tightness in the legs. Slurred or slowed speech can also develop, and gradual changes should be shared with the care team so physical therapy or mobility support can be adjusted.
Which Laurence-Moon syndrome symptoms require emergency care?
Get emergency help for sudden vision loss, severe weakness with vomiting or dehydration, confusion, fainting, or signs of dangerously low blood pressure. Sudden trouble breathing or swallowing, frequent choking, or abrupt loss of abilities also requires immediate evaluation.
Can one morning cortisol test rule out adrenal insufficiency in LMS?
No. A single morning cortisol blood test does not reliably exclude adrenal insufficiency in some people with PNPLA6-related disease, so an endocrinologist may need to arrange specialized testing based on your symptoms and history.
How can Laurence-Moon syndrome affect puberty and hormones?
Changes affecting the pituitary gland can reduce the hormones needed for sexual development, causing delayed puberty or limited development of features such as a deeper voice or breasts. Some people also have other pituitary problems, including low growth hormone, so hormone monitoring should be individualized.
How should I monitor progression of Laurence-Moon syndrome at home?
Keep a symptom log that records vision in low light, side-vision problems, walking or balance changes, leg stiffness, falls, speech changes, and episodes of weakness or vomiting. Share new or worsening symptoms with your multidisciplinary care team, even when they develop slowly.

Get notified when new evidence is published on Laurence-Moon syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Multifaceted and Age-Dependent Phenotypes Associated With Biallelic PNPLA6 Gene Variants: Eight Novel Cases and Review of the Literature.

    Nanetti L, Di Bella D, Magri S, et al.

    Frontiers in neurology 2021; (12()):793547 doi:10.3389/fneur.2021.793547.

    PMID: 35069422
  2. 2

    PNPLA6 disorders: what's in a name?

    Liu J, Hufnagel RB

    Ophthalmic genetics 2023; (44(6)):530-538 doi:10.1080/13816810.2023.2254830.

    PMID: 37732399
  3. 3

    Neuropathy target esterase activity predicts retinopathy among PNPLA6 disorders.

    Liu J, He Y, Lwin C, et al.

    bioRxiv : the preprint server for biology 2023; doi:10.1101/2023.06.09.544373.

    PMID: 37333224
  4. 4

    Novel variants in PNPLA6 causing syndromic retinal dystrophy.

    Wu S, Sun Z, Zhu T, et al.

    Experimental eye research 2021; (202()):108327 doi:10.1016/j.exer.2020.108327.

    PMID: 33141049
  5. 5

    Detailed retinal phenotype of Boucher-Neuhäuser syndrome associated with mutations in PNPLA6 mimicking choroideremia.

    O'Neil E, Serrano L, Scoles D, et al.

    Ophthalmic genetics 2019; (40(3)):267-275 doi:10.1080/13816810.2019.1605392.

    PMID: 31135245
  6. 6

    Retinal Pigment Epithelial Changes in Gordon Holmes Syndrome.

    Lu ES, Kozek LK, Martinez-Velazquez L, et al.

    Journal of vitreoretinal diseases 2026; 24741264261442895 doi:10.1177/24741264261442895.

    PMID: 42137175
  7. 7

    Homozygous PNPLA6 Mutation (p.Arg1183Trp) Associated With Isolated Cerebellar Ataxia: A Familial Case Report.

    Alawadhi A, Almarzooqi A, Khan M, Alrukn S

    Cureus 2026; (18(4)):e107039 doi:10.7759/cureus.107039.

    PMID: 42147656
  8. 8

    A novel PNPLA6 mutation in a Turkish family with intractable Holmes tremor and spastic ataxia.

    Emekli AS, Samanci B, Şimşir G, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(4)):1535-1539 doi:10.1007/s10072-020-04869-6.

    PMID: 33210227
  9. 9

    Novel PNPLA6 Variants: Hypogonadotropic Hypogonadism, Pituitary Hypoplasia, Anosmia, and Cerebellar Atrophy in Siblings.

    Hussain MA, Kumar V, Chapla A, et al.

    JCEM case reports 2026; (4(1)):luaf286 doi:10.1210/jcemcr/luaf286.

    PMID: 41356532
  10. 10

    New insights into Oliver-McFarlane syndrome: adrenocortical hypofunction and variable expressivity in a Chinese sibling pair.

    Du C, Yu T, Liu S, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(6)):622-627 doi:10.1515/jpem-2025-0731.

    PMID: 41846525
  11. 11

    PNPLA6-related syndromic retinal dystrophy: A genetically confirmed case of Boucher-Neuhauser syndrome from the Kingdom of Bahrain.

    Almohsen MA, Alasal AE, Jamal HF

    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2026; (40(3)):314-317 doi:10.4103/sjopt.sjopt_223_24.

    PMID: 42757075
  12. 12

    Oliver McFarlane syndrome: two new cases and a review of the literature.

    Lisbjerg K, Andersen MKG, Bertelsen M, et al.

    Ophthalmic genetics 2021; (42(4)):464-473 doi:10.1080/13816810.2021.1904419.

    PMID: 33818269

This page explains symptom tracking and progression in Laurence-Moon syndrome for informational purposes only and does not constitute medical advice. Your multidisciplinary care team should interpret changes and advise when urgent evaluation is needed.